Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies
- PMID: 15801070
- DOI: 10.1007/s10067-004-0937-0
Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies
Abstract
Monovariate and multivariate analyses including logistic regression were performed to determine associations among predicting variables [age, gender, immunofluorescence pattern, and anti-nuclear antibody (ANA) titer] and anti-extractable nuclear antigen (ENA) and -dsDNA antibodies (Abs) in 1089 patients with positive fluorescent ANA (FANA) test results. Samples with high titer ANAs had an increased frequency of anti-ENA and -dsDNA Abs. The receiver operating (ROC) curves of the ANA titer for anti-ENA Abs had a larger under the curve area compared to the ROC curve for anti-dsDNA Abs, indicating that ANA titer is better for predicting anti-ENA Abs than anti-dsDNA Abs. There was no relation noticed between immunofluorescence patterns and anti-ENA and -dsDNA Abs except an increased frequency of anti-dsDNA Abs found in samples with a homogeneous pattern. Probability calculations on the basis of the ANA pattern and the titer showed that samples with low titer ANAs (1:160 or less) had low probabilities for anti-ENA Abs (0.002-0.009) regardless of immunofluorescence patterns. However, samples with a homogeneous pattern at any titers including low titers had high probabilities for anti-dsDNA Abs. A decreased frequency of anti-dsDNA Abs as measured by Crithidia assay was noticed in samples from patients aged 50 or older. In contrast, no association was noticed between age and anti-ENA Abs. There was no female preponderance found in the presence of anti-ENA and -dsDNA Abs. In conclusion, our study shows that the ANA titer but not the immunofluorescence pattern is useful in predicting anti-ENA Abs. In contrast, both the ANA titer and the immunofluorescence pattern help in predicting anti-dsDNA Abs. Samples with low titer ANAs (1:160 or less) may not need a further test for anti-ENA Abs unless an ANA-associated disease is highly suspected. However, a test for anti-dsDNA Abs should be considered in samples with a homogeneous pattern at any titer including low titers.
Similar articles
-
Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.J Coll Physicians Surg Pak. 2018 Jan;28(1):40-43. doi: 10.29271/jcpsp.2018.01.40. J Coll Physicians Surg Pak. 2018. PMID: 29290190
-
Detection and identification of antinuclear antibodies (ANA) in a large community hospital.Acta Clin Belg. 2009 Jul-Aug;64(4):317-23. doi: 10.1179/acb.2009.049. Acta Clin Belg. 2009. PMID: 19810418
-
Dense fine speckled indirect immunofluorescence pattern in an Australian population.Pathology. 2016 Apr;48(3):247-50. doi: 10.1016/j.pathol.2016.02.002. Pathology. 2016. PMID: 27020500
-
Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.Autoimmun Rev. 2016 Feb;15(2):162-6. doi: 10.1016/j.autrev.2015.10.007. Epub 2015 Oct 30. Autoimmun Rev. 2016. PMID: 26524640 Review.
-
From ANA to ENA: how to proceed?Autoimmun Rev. 2006 Jan;5(1):10-7. doi: 10.1016/j.autrev.2005.05.007. Epub 2005 Jun 13. Autoimmun Rev. 2006. PMID: 16338206 Review.
Cited by
-
Determination of cut-off titers and agreement between immunofluorescence and immunoblotting methods for detecting antinuclear antibodies in children.J Clin Lab Anal. 2010;24(4):230-6. doi: 10.1002/jcla.20391. J Clin Lab Anal. 2010. PMID: 20626019 Free PMC article.
-
Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine.Biochem Med (Zagreb). 2021 Jun 15;31(2):020502. doi: 10.11613/BM.2021.020502. Epub 2021 Apr 15. Biochem Med (Zagreb). 2021. PMID: 33927550 Free PMC article. Review.
-
Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease.J Clin Lab Anal. 2012 Jul;26(4):307-14. doi: 10.1002/jcla.21522. J Clin Lab Anal. 2012. PMID: 22811366 Free PMC article.
-
Diffuse alveolar hemorrhage in children with interstitial lung disease: Determine etiologies!Pediatr Pulmonol. 2023 Apr;58(4):1106-1121. doi: 10.1002/ppul.26301. Epub 2023 Jan 13. Pediatr Pulmonol. 2023. PMID: 36588100 Free PMC article.
-
Anti-PD-1 Autoantibody Predicts Survival of Patients With Hepatocellular Carcinoma Receiving Atezolizumab/Bevacizumab.Gastro Hep Adv. 2024 Aug 2;3(8):1138-1147. doi: 10.1016/j.gastha.2024.07.018. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39559295 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources